We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The effect of COVID-19 on utilization of chronic diseases services.
- Authors
Moradi, Ghobad; Piroozi, Bakhtiar; Khayyati, Fariba; Moradpour, Farhad; Safari, Hossein; Mohamadi Bolbanabad, Amjad; Fattahi, Hamed; Younesi, Fatemeh; Ebrazeh, Ali; Shokri, Azad
- Abstract
Objectives: The aim of the present study is to evaluate the impact of Covid-19 on utilization of chronic diseases services. Methods: Interrupted time-series design was used to examine the utilization of chronic diseases services before and during the Covid-19 pandemic among hospitals in Iran. Chronic obstructive pulmonary disease (COPD), asthma, type 2 diabetes, heart failure, and chemotherapy were selected as a proxy to indicate the impact of Covid-19 on utilization of chronic diseases services. Data were collected in 24 sites from 12 months before the onset of Covid-19 (from March 2019 to February 2020) to 12 months during the Covid-19 pandemic (February 2020 to March 2021). Results: A total of 7,039,378 services were provided, of which 51.92% were provided for women and 62.73% for >65 age group. A sudden decrease was observed in monthly utilization of services during the Covid-19 pandemic; ranging from 13.91 (95% CI = −21.73, 6.10, P = 0.001) for chemotherapy to 606.39 (95% CI = −1040.72, 172.06, P = 0.009) for heart failure services per 100 thousand population. A decrease was observed in COPD services; 15.28 services compared with the period before Covid-19. Subsequently, the monthly utilization trends of asthma, type 2 diabetes, and chemotherapy services increased significantly (P < 0.05). Discussion: Although chronic diseases are a factor in more severe form of Covid-19, their failure to seek diagnostic, prevention and treatment services has somewhat complicated the issue.
- Subjects
IRAN; MEDICAL care use; RESEARCH funding; MEDICAL care; TIME series analysis; HEART failure; CHRONIC diseases; CANCER chemotherapy; OBSTRUCTIVE lung diseases; TYPE 2 diabetes; CONFIDENCE intervals; COVID-19; ASTHMA
- Publication
Chronic Illness, 2024, Vol 20, Issue 2, p309
- ISSN
1742-3953
- Publication type
Article
- DOI
10.1177/17423953231178168